Overview

Topical Avastin for Treatment of Corneal Neovascularization

Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness and safety of Topical Bevacizumab (Avastin) for treatment of corneal neovascularization.
Phase:
Phase 1
Details
Lead Sponsor:
Massachusetts Eye and Ear Infirmary
Treatments:
Bevacizumab